IBI. O. Babushkin

I. O. Babushkin

*This is an algorithmically generated author record based on publicly available information.

I. O. Babushkin has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clinical and laboratory factors determining negative outcomes of inpatients with COVID-19 in the Republic of Mordovia: a retrospective single-center study

    by L. A. Balykova, O. A. Radaeva, E. D. Kozlov, V. A. Porshina, V. V. Kulyapkin, I. O. Babushkin

    The COVID-19 pandemic, caused by the SARS-CoV-2 virus, had a profound impact on global health, and society and become one of the deadliest in history. Knowledge of risk factors for mortality is critically important in the formation of organizational, methodological and clinical decisions to limit disease progression and reduce the number of fatal outcomes. However, it is still unclear whether generally accepted risk factors can be equally useful in identifying risk groups in a diverse population of patients in small cities. Aim: To evaluate the utility of demographic, clinical, and laboratory characteristics in the prediction of negative outcome of patients with COVID-19 admitted to the intensive care unit (ICU) of the multidisciplinary COVID-19 hospital in the city of Saransk. Material and Methods. Medical records of 153 patients (including 134 recovered and 19 dead) with laboratory-confirmed SARS-CoV-2 infection treated in the intensive care unit of the S.V. Katkov Republican Clinical Hospital between March and December of 2020 were included in this retrospective, single-center, clinical trial. Demographic, clinical, and laboratory characteristics, complications and therapeutic interventions were compared between deceased and recovered patients. The primary endpoint was in-hospital all-cause mortality. Risk factors for mortality were analyzed using logistic regression. Results. Multivariate regression analysis showed that in the population studied, included both therapeutic and surgical patients, a history of coronary artery disease, chronic non-specific lung disease, acute surgical conditions, plasma creatinine at ICU admission ≥ 106 µmol/L had a negative effect on in-hospital mortality, whereas fever at admission had a protective effect. Patients who died had lower oxygen saturation upon the admission to ICU and were more likely to receive invasive mechanical ventilation and higher doses of dexamethasone in treatment. Conclusion. The present study identified predictors to mortality of patients with COVID-19, treated in the ICU of a Mordovia Republic hospital (Russia), which were somewhat different from those previously reported for larger cities and indicate a large contribution of concomitant diseases to the negative outcome. We did not identify a significant contribution of many proposed laboratory markers to predicting mortality. These findings may help authorities and clinicians optimize organizational, methodological, and clinical approaches to medical care of patients to reduce the risk of a negative outcome from COVID-19.

  • Takayasu’s arteritis: a relevant problem in modern rheumatology (a literature review)

    by Mordovian State University named after N.P. Ogareva, B.S. Suvanov, V.V. Shalin, A.A. Viryasova, A.E. Terichev, D.V. Viryasov, I.O. Babushkin, T.V. Ufaeva, O.A. Tyurina

    Takayasu’s arteritis is a rare chronic large-vessel vasculitis that predominantly affects the aorta, its major branches and pulmonary arteries. The exact occurrence rate of this pathology is unknown. However, it has been found that the disease is registered in 2.6 people per 1 million of the population in Russia, more oft en in young females. As with all rheumatic diseases, the issues of pathogenesis and therapy of non-specific aortoarteritis remain open. The complexity of pathogenetic reactions appears to be a problem for early diagnosis and selection of the correct therapy. Th is review covers the issues of pathogenesis and modern pharmacotherapy: tumor necrosis factors, pharmacotherapy and genetically engineered drugs. The review was written based on analysis of scientific literature. The eLIBRARY.RU, Cyberleninka, Pub Med, Cochrane Library databases were searched for materials published within the period of 2002-2021 with an emphasis on the past 5-10 years for the following keywords: Takayasu arteries, nonspecific aortroartery, systemic vasculitis, rheumatological diseases